Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell G Lawrence

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Cell Reports|January 6, 2021
Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate CancerRayzel C Fernandes, John Toubia, Scott Townley, et al.
European Urology Focus|April 12, 2025
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated VariantsMitchell G Lawrence, Shivakumar Keerthikumar, Scott L Townley, et al.
Cancer Research Communications|March 16, 2023
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate CancerMohammadreza Alizadeh-Ghodsi, Katie L Owen, Scott L Townley, et al.
The Prostate|March 7, 2024
Defining the challenges and opportunities for using patient-derived models in prostate cancer researchW Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, et al.
Genome Research|April 14, 2018
Enduring epigenetic landmarks define the cancer microenvironmentRuth Pidsley, Mitchell G Lawrence, Elena Zotenko, et al.
Nature Communications|January 10, 2017
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectoriesRenea A Taylor, Michael Fraser, Julie Livingstone, et al.
Nature Communications|August 20, 2021
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncologyGail P Risbridger, Ashlee K Clark, Laura H Porter, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Nature Biotechnology|September 13, 2016
A community-based model of rapid autopsy in end-stage cancer patientsKathryn Alsop, Heather Thorne, Shahneen Sandhu, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Cell Reports|January 6, 2021
Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate CancerRayzel C Fernandes, John Toubia, Scott Townley, et al.
European Urology Focus|April 12, 2025
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated VariantsMitchell G Lawrence, Shivakumar Keerthikumar, Scott L Townley, et al.
Cancer Research Communications|March 16, 2023
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate CancerMohammadreza Alizadeh-Ghodsi, Katie L Owen, Scott L Townley, et al.
The Prostate|March 7, 2024
Defining the challenges and opportunities for using patient-derived models in prostate cancer researchW Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, et al.
Genome Research|April 14, 2018
Enduring epigenetic landmarks define the cancer microenvironmentRuth Pidsley, Mitchell G Lawrence, Elena Zotenko, et al.
Nature Communications|January 10, 2017
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectoriesRenea A Taylor, Michael Fraser, Julie Livingstone, et al.
Nature Communications|August 20, 2021
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncologyGail P Risbridger, Ashlee K Clark, Laura H Porter, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Nature Biotechnology|September 13, 2016
A community-based model of rapid autopsy in end-stage cancer patientsKathryn Alsop, Heather Thorne, Shahneen Sandhu, et al.
Pageof 6